ZFYVE19
Basic information
Region (hg38): 15:40807086-40815084
Links
Phenotypes
GenCC
Source:
- cholestasis, progressive familial intrahepatic, 9 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Cholestasis, progressive familial intrahepatic, 9 | AR | Gastrointestinal | The condition involves sequelae of cholestasis, and medical management (with ursodeoxycholic acid) has been described as beneficial; Liver transplant has been described | Gastrointestinal | 32737136; 33853651 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (62 variants)
- Cholestasis,_progressive_familial_intrahepatic,_9 (9 variants)
- not_provided (4 variants)
- ZFYVE19-related_disorder (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZFYVE19 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001077268.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 57 | 66 | ||||
| nonsense | 6 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 6 | 2 | 57 | 9 | 0 |
Highest pathogenic variant AF is 0.000029737897
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ZFYVE19 | protein_coding | protein_coding | ENST00000355341 | 11 | 7484 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 3.20e-14 | 0.142 | 124740 | 0 | 84 | 124824 | 0.000337 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.445 | 251 | 272 | 0.924 | 0.0000153 | 2989 |
| Missense in Polyphen | 62 | 73.807 | 0.84003 | 883 | ||
| Synonymous | 0.135 | 102 | 104 | 0.983 | 0.00000546 | 943 |
| Loss of Function | 0.942 | 24 | 29.5 | 0.813 | 0.00000171 | 281 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000386 | 0.000386 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00201 | 0.00200 |
| Finnish | 0.0000464 | 0.0000464 |
| European (Non-Finnish) | 0.000239 | 0.000238 |
| Middle Eastern | 0.00201 | 0.00200 |
| South Asian | 0.000230 | 0.000229 |
| Other | 0.000167 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Key regulator of abscission step in cytokinesis: part of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage. Together with CHMP4C, required to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis. Deactivation of AURKB results in dephosphorylation of CHMP4C followed by its dissociation from ZFYVE19/ANCHR and VPS4 and subsequent abscission. {ECO:0000269|PubMed:24814515}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving ZFYVE19 is associated with acute myeloblastic leukemia (AML). Translocation t(11;15)(q23;q14) with KMT2A/MLL1 (PubMed:12618766). {ECO:0000269|PubMed:12618766}.;
Intolerance Scores
- loftool
- 0.737
- rvis_EVS
- 1.62
- rvis_percentile_EVS
- 96.01
Haploinsufficiency Scores
- pHI
- 0.0323
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.425
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.465
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zfyve19
- Phenotype
Gene ontology
- Biological process
- abscission;negative regulation of cytokinesis;mitotic cytokinesis checkpoint;cell division
- Cellular component
- cytoplasm;centrosome;midbody;cleavage furrow;Flemming body
- Molecular function
- protein binding;phosphatidylinositol-3-phosphate binding;metal ion binding